Compugen Ltd. (CGEN)

Nasdaq: CGEN · Biological Products, (No Diagnostic Substances) · Holon, IL · filing with the SEC since 2001

Full chart Alerts Compare

Grade6.8

◀ Past 6.1● Present 7.2▶ Future 6.9

1 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

The grade of Compugen Ltd.

Nine metrics read from its own filings, by tense

Headline grade

6.8/10

◀ Past6.130% of the headline

● Present7.240% of the headline

▶ Future6.930% of the headline

All three tenses have at least two readings, so the archetype blend applies as printed.

Of the nine metrics, 8 read as filed from the record and 1 is an SI estimate, each with its reasoning, its confidence and what would change it on its card.

◀ Past

What did they actually do?

6.1/1030% of the headline grade · 3 of 3 filed

Surviving crises

as filed

8.0/10

Has it survived what it has been through?

No warning events in its filings since 2017.

weight 33% of this tense · 80th percentile among 159 sector filers · read for itself

From the record

Compugen Ltd.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Track record

as filed

5.1/10

What has it actually done, year after year?

+17.5% a year over 10 filed years; profitable in 1 of 10.

weight 45% of this tense · 51st percentile among 102 sector filers · read for its customers

From the record

Compugen Ltd.'s 10 filed years say what it did: revenue went from $12 million in fiscal 2014 to $73 million in fiscal 2025, up 17.5% a year; it rose in 5 of 9 years; the deepest fall was 94% from fiscal 2014 to fiscal 2016; net income was positive in 1 of 10 of those years (its annual reports).

What it rests on

revenue growth over the filed span17.5%top 47% of its family
the share of years revenue rosetop 48% of its family
the share of filed years with a profittop 35% of its family
the deepest fall from a revenue peak94.2%bottom 32% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Shareholder treatment

as filed

5.3/10

How has it treated the people who own it?

Share count grew 2.7% a year. 0% of cash flow returned. Insiders: 12 sales, 0 purchases.

weight 22% of this tense · 54th percentile among 21 sector filers · read for its shareholders

From the record

Over the 3 fiscal years to 2025-12-31, Compugen Ltd.'s diluted share count grew about 2.7% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 12 sales (12 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-09-30 (their Form 4 filings).

What it rests on

the share count over the yearstop 17% of its family
cash returned against operating cash flowbottom 24% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

● Present

What are they doing right now?

7.2/1040% of the headline grade · 2 of 3 filed, 1 estimated

Financial health

as filed

7.5/10

Is it financially healthy right now?

ROE 34%: 34¢ of profit per shareholder dollar. Leverage 34%: owes 34¢ per asset dollar.

weight 45% of this tense · 75th percentile among 147 sector filers · read for itself

From the record

Return on equity: in the fiscal year ended 2025-12-31, Compugen Ltd. earned about 34 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 41 cents per dollar of everything the company owns. Leverage: it owed about 34 cents per dollar of assets, and net share issuance: its share count grew 4.8% over the year (the filed statements).

What it rests on

what it owes per dollar of assetstop 48% of its family
return on equitytop 5% of its family
gross profit against assetstop 20% of its family
the share count against the year beforetop 26% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Industry position

as filed

8.2/10

How strong is its position in its industry?

top 18% of 102 in its family; net margin 48.6%.

weight 33% of this tense · 82nd percentile among 102 sector filers · read for its customers

From the record

Compugen Ltd.'s standing among 102 graded names in its industry family: revenue of $73 million in fiscal 2025 ranks in the top 36% by size; a net margin of 48.6% ranks in the top 3%; revenue growth of 113.2% a year over the last 3 filed years ranks in the top 13% (its annual reports).

What it rests on

revenue against the family$72.8Mtop 36% of its family
net margin48.6%top 3% of its family
three-year revenue growth113.2%top 13% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Leadership

SI estimate

5.0/10

What are the people in charge doing?

SI estimate 5.0/10, confidence 20 of 100 (family median).

weight 22% of this tense · 50th percentile among 130 sector filers · read for its shareholders

SI estimate Inferred, not read as filed

Why it is an estimate: It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 130 members with one.
What the record cannot read: It files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge.
How it was reasoned: family median, 130 readings behind it.
Confidence: 20 of 100
What would change it: Its next annual report on file with the inputs replaces this estimate with the filed reading.

From the record

SI estimate, not a filed reading: Compugen Ltd.'s leadership is put at 5.0 of 10 with a confidence of 20 of 100, because it files no Form 8-K (a foreign issuer reports on Form 6-K), so officer and director changes cannot be read there; the record of its people begins on 2026-03-18 (a listing, a merger or a first filing under the rules) and its chief executive and most of the people in charge have filed since then, so the record shows a floor of 8 months and cannot see past it; a floor under five years is not read as years in charge, so the desk assumes the typical reading of its industry family, the median of 130 members with one. Its next annual report on file with the inputs replaces this estimate with the filed reading.

▶ Future

What are they set up to do next?

6.9/1030% of the headline grade · 3 of 3 filed

Room to expand

as filed

6.6/10

How much room does it have to grow?

top 34% of 92 in its family for room to expand.

weight 45% of this tense · 66th percentile among 92 sector filers · read for itself

From the record

Compugen Ltd.'s room to grow, from the newest filed statements (fiscal 2025): cash of $91 million against no long-term debt tagged leaves 57.9% of its assets as net cash, top 27% of its family; cash from operations less capital spending is 43.1% of revenue (top 3%); a gross margin of 87.3% (top 29%); research spending of 31.3% of revenue (bottom 21%) (its annual report).

What it rests on

cash less debt against assets57.9%top 27% of its family
cash from operations less capital spending against revenue43.1%top 3% of its family
gross margin87.3%top 29% of its family
research spending against revenue31.3%bottom 21% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Growth drivers

as filed

6.9/10

What could actually drive growth from here?

top 31% of 100 in its family for growth drivers.

weight 33% of this tense · 69th percentile among 100 sector filers · read for its customers

From the record

Compugen Ltd.'s growth drivers, from the filed years to fiscal 2025: revenue grew 113.2% a year over the last three filed years against 17.5% over all 10, speeding up (top 5% of its family); the newest year grew 161.3% (top 14%); research spending grew -9.4% a year (bottom 28%); capital spending grew -13.8% a year (top 34%) (its annual reports). Compugen Ltd. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

What it rests on

three-year growth against the whole span+95.8 points a yeartop 5% of its family
the newest year's revenue growth161.3%top 14% of its family
three-year growth of research spending-9.4%bottom 28% of its family
three-year growth of capital spending-13.8%top 34% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

Expectations vs reality

as filed

7.6/10

Did its newest year beat what its own record pointed to?

top 24% of 72 in its family for expectations against reality.

weight 22% of this tense · 76th percentile among 72 sector filers · read for its shareholders

From the record

Compugen Ltd.'s newest year against its own record: revenue of $73 million in fiscal 2025 came in 35.5% above the $54 million its prior three years' pace pointed to (top 33% of its family); net income of $35 million against a prior three-year average of $22 million (top 4%); a net margin of 48.6% against losses larger than its revenue before (top 35%) (its annual reports).

What it rests on

revenue against the prior three years' pace35.5%top 33% of its family
net income against the prior three years' average+259%top 4% of its family
net margin against its prior averageup more than 100 pointstop 35% of its family

A production reading, recomputed from the filings on every data build, read from EDGAR Nov 13, 2026.

The grade is the company against its own industry, from its filings. It is not a view on the share price. How the grade is made

SI Assistanton CGEN · research, not advice